home | about us | attorneys | actos | bladder cancer | faqs | articles | law resources | press release | contact us | blog | Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +
Judge assigns 19 lawyers to oversee Actos cases
Posted on March 26th, 2012
No Comments
The judge in the Actos case has now assigned 19 plaintiff’s lawyers to help with the litigation process for the U.S. lawsuits. These lawsuits have been filed against the makers of Actos, Takeda Pharmaceuticals, and claim that the company withheld information about the medication causing an increased risk of bladder cancer. Actos, is a prescription [...]
Takeda may face more than 10,000 Actos lawsuits
Posted on March 19th, 2012
No Comments
The largest drugmaker in Asia, Takeda Pharmaceuticals, may now face nearly 10,000 lawsuits over the Type 2 diabetes medication, Actos. The cases were consolidated in December and the first hearings are set to be heard in March. These lawsuits claim that Actos increased their risk of developing bladder cancer when used for over a year. [...]
Actos: Whistleblower in case alleges officials hid bladder cancer risks
Posted on March 12th, 2012
No Comments
A U.S. District Judge has recently made the order to unseal a whistleblower case of the former medical reviewer for Takeda Pharmaceuticals involving the failure to report bladder cancer risks from the use of the popular Type 2 diabetes medication, Actos. The whistleblower is a doctor and former safety reviewer for Takeda who worked to [...]
Screening tests for bladder cancer
Posted on March 5th, 2012
No Comments
Bladder cancer is the fifth most common cancer that women and men are diagnosed with. Each year, there are 71,000 new cases and 14,000 deaths. Risk factors for bladder cancer include occupational exposure, smoking and being exposed to certain infections from parasites and having a family history of bladder cancer. Also, men have higher diagnosed [...]
Takeda’s new anemia treatment in review by EMA
Posted on March 1st, 2012
No Comments
A new anemia drug developed by Takeda Pharmaceuticals has been accepted for review by the European Medicines Agency. The new drug is designed to be taken once a month for patients with anemia from chronic kidney disease and was discovered by Affymax. If approved by the EMA, Takeda will market the product solely in Europe. [...]
By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.
Archives
- April 2013
- February 2013
- January 2013
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
Categories
- Actos and bladder cancer lawyers (17)
- Actos attorneys (12)
- Actos bladder cancer attorneys (9)
- Actos bladder cancer lawsuit attorneys (9)
- Actos bladder cancer lawsuit lawyers (16)
- Actos bladder cancer lawyers (25)
- Actos lawsuit attorneys (26)
- Actos lawsuit lawyers (24)
- Actos lawyers (8)
- Actos mass tort attorneys (2)
- Actos side effects lawyers (3)
- Bladder Cancer and Actos (1)
- bladder cancer symptoms lawyers (4)
- bladder cancer treatments (1)
- Diabetes drug side effect (3)
- Risk of diabetes (1)
- Takeda Pharmaceuticals (4)
- Uncategorized (1)
Blogroll
- Accutane Lawsuit Attorney
- Depakote Lawyers
- Depuy Lawsuit Attorney
- Mesothelioma Lawyers
- Reglan Lawsuit Attorney
- Topamax Lawsuit Attorney